期刊文献+

从电性参数和分子体积预测药物的血浆蛋白结合率

PREDICTING DRUG-PROTEIN BINDING FROM ELECTRONIC PARAMETERS AND MOLECULAR VOLUME
下载PDF
导出
摘要 目的:从电性参数和分子体积预测药物的血浆蛋白结合率。方法:根据半经验自洽场分子轨道AM1法得到的优化构型用Monte Carlo法计算得到分子体积。用逐步多元回归分析法建立从药物的电性参数、脂溶性和分子体积预测14种不同结构药物牛血清白蛋白结合率的数学模型。回归方程采用statistics60软件进行逐步多元回归分析得到。结果:13种不同结构药物的牛血清白蛋白结合率与分子酸碱性指示变量和分子体积有良好的相关性。回归方程为:%B(DAB)=187.42-39.47I+1.0×10-3V2-0.77V(n=13,R=0.9632)。结论:药物血浆蛋白结合率与分子的电性和分子体积密切相关。从分子电性参数和分子体积预测药物血浆蛋白结合率具有方便快捷的优点,可用于相关的药动学参数的研究。 Objective: To predict the percentage of drug - protein binding from electronic parameters and molecular volume. Methods:Moot Carlo method was used to obtain the molecular volume from their minimum energy conformations obtained from the optimization of the standard molecular geometry with the semiempirical self - consistent field molecular orbital calculation AM1 method. The stepwise multiple regression analysis was used to establish the model of predicting 14 drugs fraction bound to bovine serum albumin[ % B (DAB)] from electronic parameters, lipophilicity and molecular volume. The stepwise multiple regression analysis with statistics 60 was used to obtain the correlation equations. Results:Both indicator variables of acid and base and molecular volume are well correlated with the 13 drugs fraction bound to bovine serum albumin. The correlation equation is % B(DAB) = 187.42 - 39. 471 + 1.0×10 - 3V2 - 0. 77V( n = 13, R = 0. 9632 ). Conclusion: Conclusion : Drug - protein binding is closely related with the drug, s electronic parameters and molecular volume. The advantage of this research is that electronic parameters and molecular volume can be computed simply. It can also infer this method may be used to study other pharmaeokinetics parameters.
出处 《牡丹江医学院学报》 2008年第5期12-16,共5页 Journal of Mudanjiang Medical University
关键词 血浆蛋白结合率 电性参数 分子体积 drug - protein binding electronic parameters molecular volume
  • 相关文献

参考文献19

  • 1FICHTL B, NIECIECKI A, WALTER K. Tissue binding versus plasma binding of drugs: General principles and pharmacokinetics consequences [J]. Adv Drug Res,1991,20:118 -166.
  • 2BENET LZ, KROETZ DL, SHEINER LB. Pharmacokinetics: The dynamics of drug absorption distribution and elimination. In: Hardman JG, Limbird LE (ed.) Goodman & Gilman' The pharmacological basis of therapeutics [ M ]. 9ed, New York : McGraw - Hill, 1996 : 3 - 27.
  • 3David S. Hage, Stacey A. Tweed. Recent advances in chromatographic and electrophoretic methods for the study of drug - protein interactions [J]. J Chroma B, 1997,699:499 - 525.
  • 4Jana Oravcova, Barbara Bohs, Wolfgang Lindner. Drug -protein binding studies New trends in analytical and experimental methodology[ J ] . J Chrema B, 1996,677 : 1 - 28.
  • 5Yuming Huang,zhujun Zhang. Binding study of drug with bovine serum albumin using a combined technique of microdialysis with flow - injection chemiluminescent detectiorl [ J ]. J Pharm Biomed Anal, 2004,35:1293 - 1299.
  • 6Laurence D, Fabienne P, Maryline J, Bernard B. Relationship between lipophilicity and binding to human serum albumin of arylpropionic acid non - steroidal anti - inflammatory drugs [ J ]. J Pharma Biomed Analy, 1997,16:223 - 229.
  • 7Claudia S, Pier V, Fabrizio B, et al. Structure - property relationships on histamine H3 - antagonists : binding of phenyl - substituted alkyl- thioimidazole derivatives to rat plasma proteins[J]. Ⅱ Farmaco,2000, 55:239 - 245.
  • 8V. Andrisano, R. Gotti, M. Recanatini, A. Cavalli, L. Varoli, C. Bertucci. Stereoselective binding of 2 - (4 - biphenylyl ) - 3 - substituted- 3 -hydroxypropionic acids on immobilished human serum albumin chiral stationary phase [ J ] . J Chroma B, 2002, 768 : 137 - 115.
  • 9L Mark Hall, Lowell H. Hall, Lemont B. Kier. Modeling Drug Albumin Binding Affinity with E - State Topological Structure Representation [ J ]. J. Chem. Inf. Comput. Sci. 2003,43:2120 - 28.
  • 10Joseph V. Turner, Desmond J. Maddalena, David J, Cutler. Pharmacokinetic parameter prediction from drug structure using artificial neural networks[ J]. Intern J Pharm ,2004,270:209 -219.

二级参考文献17

  • 1傅旭春,孙群.β受体阻断剂的小肠吸收速率与分子结构的相关性[J].浙江大学学报(医学版),2005,34(2):177-180. 被引量:3
  • 2傅旭春,詹淑玉.从极性原子净电荷预测药物在人体小肠中的吸收[J].浙江大学学报(医学版),2006,35(2):199-203. 被引量:2
  • 3FICHTL B,NIECIECKI A,WALTER K.Tissue binding versus plasma binding of drugs:General principles and pharmacokinetics consequences[J].Adv Drug Res,1991,20:118-166.
  • 4BENET L Z,KROETZ D L,SHEINER L B.Pharmacokinetics:The dynamics of drug absorption distribution and elimination.In:Goodman & Gilman' The pharmacological basis of therapeutics[M].9ed,New York:McGraw-Hill,1996:3-27.
  • 5HAGE D S,TWEED S A.Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions[J].J Chroma B,1997,699:499-525.
  • 6ORAVCOVA J,BOHS B,LINDNER W.Drugprotein binding studies.New trends in analytical and experimental methodology[J].J Chroma B,1996,677:1-28.
  • 7HUANG Y M,ZHANG Z J.Binding study of drug with bovine serum albumin using a combined technique of microdialysis with flowinjection chemiluminescent detection[J].J Pharm Biomed Anal,2004,35:1 293-1 299.
  • 8GOBBURU J V S,SHELVER W H.Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks[J].J Pharm Sci,1995,84:862-865.
  • 9DESCHAMPS-LABAT L,PEHOURCQ F,JAGOU M,BANNWARTH B.Relationship between lipophilicity and binding to human serum albumin of arylpropionic acid nonsteroidal anti-inflammatory drugs[J].J Pharm Biomed Anal,1997,16:223-229.
  • 10ZLOTOS G,BUCKER A,JURGENS J,HOLZGRABE U.Protein binding in a congeneric series of antibacterial quinolone derivatives[J].Int J Pharm,1998,169:229-238.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部